TriSalus Life Sciences (TLSIW) Net Margin (2022 - 2026)
TriSalus Life Sciences posted quarterly Net Margin of 17.29% for Q1 2026, up 13824.0% year-on-year from N/an in Q1 2025, and up 123.42% on a QoQ basis from 73.86% in Q4 2025.
TriSalus Life Sciences (TLSIW) has 5 years of Net Margin data on file, last reported at 17.29% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 13824.0% year-over-year to 17.29%; the trailing twelve-month figure through Mar 2026 stood at 130.32% (down 3600.0% YoY), and the FY2025 full-year result was 154.35%, down 4143.0% from the prior year.
- Net Margin for Q1 2026 stood at 17.29%, up from 73.86% in the prior quarter.
- Across five years, Net Margin topped out at 17.29% in Q1 2026 and bottomed at 786.45% in Q4 2022.
- The 5-year median for Net Margin is 131.84% (2024), against an average of 226.58%.
- The widest annual swing landed in 2024, when Net Margin surged 50510 bps; it then tumbled 31329 bps in 2025.
- A 5-year view of Net Margin shows it stood at 786.45% in 2022, then advanced by 19 bps to 636.93% in 2023, then soared by 79 bps to 131.84% in 2024, then surged by 44 bps to 73.86% in 2025, then jumped by 123 bps to 17.29% in 2026.
- The last three Net Margin figures came in at 17.29% (Q1 2026), 73.86% (Q4 2025), and 356.86% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | 17.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.29% |
| Dec 31, 2025 | -73.86% |
| Sep 30, 2025 | -356.86% |
| Jun 30, 2025 | -80.28% |
| Mar 31, 2025 | -120.94% |
| Dec 31, 2024 | -131.84% |
| Sep 30, 2024 | -43.57% |
| Jun 30, 2024 | -69.70% |
| Mar 31, 2024 | -216.93% |
| Dec 31, 2023 | -636.93% |
| Sep 30, 2023 | -36.26% |
| Jun 30, 2023 | -346.83% |
| Mar 31, 2023 | -309.22% |
| Dec 31, 2022 | -786.45% |
| Sep 30, 2022 | -206.30% |